Acasti Pharma Inc - Class A ACST Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$3.30 up $0.19, 6.11% on Oct 24
Last price · Previous close $3.11
- Market cap
- At the last price
- P/E ratio
- On last 12 months’ EPS
- Diluted EPS
- Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$3.30up $0.19, 6.11%Thu, Oct 24 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$3.11Oct 7
- Volume12.26KOct 7 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume39.43KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the last price. Total return includes reinvested dividends.Price change only, without dividends.
| Period | ACST |
|---|---|
| Short term | |
| 1M | ACST: up 28.9% |
| 3M | ACST: up 12.2% |
| YTD | ACST: up 14.2% |
| 1Y | ACST: up 37.5% |
| Long term | |
| 3Y | ACST: down 67.3% −31.1% a year |
| 5Y | ACST: down 96.8% −49.9% a year |
| 10Y | ACST: down 98.7% −35.5% a year |
$10,000 invested in ACST 10 years ago (Oct 17, 2014) would be worth about $125 as of , with dividends reinvested.
| Period | ACST |
|---|---|
| Short term | |
| 1M | ACST: up 28.9% |
| 3M | ACST: up 12.2% |
| YTD | ACST: up 14.2% |
| 1Y | ACST: up 37.5% |
| Long term | |
| 3Y | ACST: down 67.3% −31.1% a year |
| 5Y | ACST: down 96.8% −49.9% a year |
| 10Y | ACST: down 98.7% −35.5% a year |
$10,000 invested in ACST 10 years ago (Oct 17, 2014) would be worth about $125 as of , not counting dividends.
All-time high
$1,953.60
Closing high on . Now 99.8% below that record.
Split-adjusted daily closes since May 6, 2011.
Stock splits
3
Latest: 1-for-6 on . Share counts adjust after each split.
All 3 splits
- 1-for-6
- 1-for-8
- 1-for-10
Valuation
Financials
About Acasti Pharma Inc - Class A
Acasti Pharma Inc. (Acasti) is engaged in developing a product portfolio of long-chain omega-3 phospholipids. Acasti is a majority owned subsidiary of Neptune Technologies and Bioressources Inc. (Neptune). The Company has one operating segment: the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. The Company's product portfolio includes concentrated phospholipids which functionalize eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Acasti is the producer of anti-dyslipidemic prescription drugs (CaPre), medical foods (Onemia) and over-the-counter (OTC) products (Vectos). During the fiscal year ended February 28, 2011 (fiscal 2011), the Company has completed the development and launched medical food, Onemia.
- Sector
- Industry
- Headquarters
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
ACST news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
ACST stock FAQ
What is ACST stock’s price today?
Acasti Pharma (ACST) traded at $3.30 as of , up $0.19 (6.11%) from the previous close of $3.11.
If you invested $1,000 in ACST 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in ACST on would be worth about $13 as of , a total return of −98.7%. The same $1,000 would be worth $32 if invested five years ago and $1,375 if invested one year ago. Past performance doesn’t predict future returns.
Does ACST pay a dividend?
Acasti Pharma hasn’t paid a dividend in the last twelve months.
What is ACST’s all-time high?
ACST’s highest closing price was $1,953.60 on , adjusted for stock splits. At $3.30 as of , it is 99.8% below that record.
Has ACST stock ever split?
Yes, three times: 1-for-10 on ; 1-for-8 on ; 1-for-6 on .
How has ACST stock performed?
Including dividends and measured to the last price on , ACST has returned +14.2% so far this year and +37.5% over the past year, and −96.8% over five years (−49.9% a year). Past performance doesn’t predict future returns.
What exchange does ACST trade on?
Acasti Pharma trades on the Nasdaq under the ticker symbol ACST. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.